Project CBD

NOVEMBER 11, 2023

In general, I think that botanical medicine is safer than pharmaceutical medicine, that the chances of causing harm are much less. I have many patients that want to use cannabis, and they who ask me what product should they get? I include pharmaceutical drugs in that category. Cannabis is a really special case.

Medicine 306

Medicine Research and Development Pharmaceutical Cannabis 306

Cannabis Law Report

JULY 29, 2021

This initial export to Austria marks Avicanna’s first commercial export of psychoactive THC Cannabis Extracts into the emerging European medicinal cannabis market. Initial shipment of THC extracts into the European Union.

Extraction 98

Extraction Supply Chain THC Research and Development 98

Cannabis Law Report

AUGUST 12, 2022

. – August 11, 2022) – MOTAGON, a pharmaceutical company based in Prague and specializing in medical cannabis, has secured a ground-breaking agreement with Europe’s biggest indoor cannabis producer and one of the first cannabis extracts and formulations producers PHCANN INTERNATIONAL. ”

Extraction 52

Extraction Pharmaceutical Patients THC 52

Cannabis Law Report

JUNE 23, 2021

Valcon Medical A/S Announces Receipt of EU GMP Certification and Start of Commercial Production for Pharmaceutical-Grade Cannabis Concentrates, Intermediary Products, and Medical Formulations (PRNewsfoto/Valcon Medical A/S). and BÜCHI Labortechnik AG, both leaders in cannabis production and processing services. About Valcon Medical.

Pharmaceutical 86

Pharmaceutical Concentrates Extraction Medicine 86

FloridaMarijuana.net

OCTOBER 5, 2018

In particular, terpenoids are contained in many herbal plants, and several terpenoids have been shown to be available for pharmaceutical applications. Phytol is considered a diterpene , present in cannabis extracts, as a breakdown product of chlorophyll and tocopherol.

Terpenes 181

Terpenes Strains Oil Medicine 181

FloridaMarijuana.net

AUGUST 15, 2018

Most commonly, patients report that tingling and numbness occur, usually in the hands and feet. Six trials that included 325 patients examined chronic pain, 6 trials that included 396 patients investigated neuropathic pain, and 12 trials that included 1600 patients focused on multiple sclerosis.

Chronic Pain 150

Chronic Pain Marijuana Patients Clinical Trials 150

Cannabis Law Report

DECEMBER 23, 2021

DUBLIN–(BUSINESS WIRE)– “The Pharmaceutical Cannabis Report: 2nd Edition” report has been added to ResearchAndMarkets.com’s offering. In both Europe and the United States, the sales of unapproved cannabis products such as smokable flower and full spectrum oils dwarf those of approved pharmaceuticals.

Pharmaceutical 74

Pharmaceutical Clinical Trials Research and Development Cannabinoids 74

Cannabis Law Report

AUGUST 18, 2021

Seed confirmed on Tuesday that Eurox had successfully launched its own “unique” brand of ‘made in Germany’ full-spectrum medical cannabis extracts, representing a milestone for the company, with products now available for German pharmacies to order. Seed has an 8.85% shareholding in Eurox.

Extraction 105

Extraction Pharmaceutical THC Patients 105

Cannabis Law Report

JUNE 5, 2019

Press Release: Thailand Government Pharmaceutical Organization. The Pharmaceutical Organization, Department of Medical Affairs, signed a joint research on standard quality medical marijuana extracts for patients with chemo-allergic cancer, epilepsy, muscle contraction in patients with deteriorating nerve sheaths.

Pharmaceutical 40

Pharmaceutical Extraction Epilepsy Research and Development 40

Cannabis Law Report

MAY 26, 2023

Multinational operator to supply pharmaceutical-grade CBD extract for European patients TOCANCIPÁ, Colombia, May 25, 2023 (GLOBE NEWSWIRE) — Clever Leaves Holdings Inc.

Pharmaceutical 52

Pharmaceutical Extraction Medicine CBD 52

Greencamp

MAY 1, 2019

Since then, countless patients found relief in cannabis, even though most of the times doctors would only recommend it when all other “mainstream” options were exhausted. However, some people don’t react well to antiemetics—most notably cancer patients going through aggressive chemo. And that’s where cannabis comes into play.

Patients 89

Patients Strains Sativa Marijuana 89

The Cannigma

FEBRUARY 1, 2023

Patients are often left to their own devices when looking into cannabis and cancer, given the lack of clinical evidence, and stigma surrounding the use of the plant as medicine. His team is using novel techniques aimed at untangling the complex interactions between specific plant extracts with cancer cancer cells. The answer: Maybe!

Clinical Trials 145

Clinical Trials Research and Development Therapy Cannabinoids 145

Cannabis Law Report

JUNE 28, 2021

Pharmaceutical and Medical Cannabis Leaders Zambon GmbH and Adven GmbH will Drive Medical Cannabis Supporting Treatments for Neurological Therapies. The aim of the agreement is to make medical cannabis treatments available to patients, with an initial focus on neurological therapies. The market for medical cannabis in Germany.

Access 105

Access Research and Development Pharmaceutical Therapy 105

Cannabis Law Report

JULY 2, 2021

CannaVerde Pharma is a vertically integrated medical cannabis company with core operations in Colombia, focused on delivering low-cost, pharmaceutical grade, EU-GMP compliant cannabis-based products to consumers and medical patients in Latin America and Europe. Company Overview. High Margin Revenue Streams. Full Suite of Licenses.

Sleep 105

Sleep Pharmaceutical THC Extraction 105

Cannabis Law Report

FEBRUARY 18, 2022

We are one of the first to successfully complete a commercial shipment of Colombian-manufactured high-CBD pharmaceutical product to Germany available for patients in pharmacies under prescription. Ethypharm aspires to work closely with doctors and pharmacists to improve patients’ lives.

Extraction 52

Extraction Pharmaceutical Patients Cannabinoids 52

FloridaMarijuana.net

JUNE 19, 2018

Sometimes traditional veterinary pharmaceuticals may not always be effective for dogs and cats and the side-effects may interfere with a pet’s quality of life. These are administered similar to pharmaceuticals, but without the harmful side effects. When a pet is ill, it can feel like a member of the family is suffering.

Pets 186

Pets CBD Tincture Oil 186

Canna Care Docs

JUNE 22, 2018

An Introductory Lesson on THC Basics For Medical Cannabis Patients. Cannabis, a plant that has proven to be endlessly complex is still under the microscope by researchers, patients, physicians, and society. But many new patients need an introduction on THC basics, learning how it plays a role in a patient’s well-being and healing.

THC 66

THC Patients Blood Pressure Clinical Trials 66

Veriheal

MAY 9, 2022

This cannabis-based drug, or rather miraculous medication, is a botanical combination of extracts from the Cyathus striatus fungus and cannabis. The cannabinoid and fungus extract duo was able to eliminate 100% of the pancreatic cancer cells in the model and it did so without damaging normal cells.

Research and Development 23

Research and Development Extraction Treatment Cannabinoids 23

MJ Business Attorneys

JUNE 29, 2018

Epidiolex is the first drug the FDA has approved that contains a substance derived from marijuana, and it is also the first drug approved by the FDA to be used to treat patients with Dravet syndrome.

DEA 113

DEA CBD Pharmaceutical Research and Development 113

Project CBD

MAY 3, 2023

Dr. Goldstein has treated thousands of patients with medical cannabis. Remember, the pharmaceutical model is “this medicine addresses this specific target.” There are pharmaceuticals for ADHD or behavioral issues, for example, which target this receptor. I have used it in some of my patients with autism.

Cannabinoids 213

Cannabinoids Sleep Clinical Trials CBD 213

Cannabis Law Report

NOVEMBER 3, 2021

This is a strategic opportunity for us to reach the widest audience of customers possible while being the first and, at the moment, the only company with a permit to market cannabis extracts for inhalation in Germany specifically and in Europe in general.

Extraction 52

Extraction Pharmaceutical Patients Treatment 52

United Patients Group

APRIL 18, 2023

Because they often combine it with other drugs like cocaine or heroin or even legal ‘prescribed’ pharmaceuticals–and those are far more dangerous than cannabis itself! In fact, there are some patients who prefer not to smoke because of their health conditions or other reasons. Myth: Cannabis is a cure-all.

Research and Development 116

Research and Development Indica Treatment Conditions 116

Canna Care Docs

OCTOBER 3, 2023

On top of overwhelming struggles or feelings, patients who have been diagnosed with a terminal illness can face a broad range of both physical and psychological effects. However, many of these pharmaceutical medications can just induce more unpleasant, debilitating effects on those who are ill.

Chronic Pain 105

Chronic Pain Clinical Trials Patients Cannabinoids 105

Cannabis Law Report

DECEMBER 15, 2021

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC ) has entered into an agreement to divest its subsidiary business, C³ Cannabinoid Compound Company GmbH (“C3”), to Dermapharm Holding SE (“Dermapharm”) (WKN: A2GS5D, ISIN: DE000A2GS5D8), a European pharmaceutical company headquartered in Grünwald, Germany.

Pharmaceutical 52

Pharmaceutical Cannabinoids Business Extraction 52

MedicalJane

MAY 21, 2020

The UNM researchers set out to examine the effectiveness of consuming “legal” hemp oil extracted from the whole Cannabis plant. A chronic neuropathic pain model was used that exposed mice to post-operative neuropathic pain equivalent to several years of chronic pain in human patients. Westlund, Department of Anesthesiology.

Oil 100

Oil Hemp Extraction Clinical Trials 100

Cannabis Law Report

JUNE 21, 2021

Dr. Dadi Segal , Founder and CEO of Panaxia Israel : “We are excited to be the first and exclusive company in Europe to receive a marketing permit for inhaled medical cannabis extracts.

Extraction 45

Extraction Pharmaceutical Research and Development Patients 45

Cannabis Law Report

AUGUST 9, 2021

The company’s innovative technology enables the provision of an exact amount of active ingredients through oral ingestion, using a high concentration of cannabinoids or medical cannabis extract in a homogeneous, uniform and stable formulation which can be administered in the form of oral capsules, syrups or buccal sprays.

Cannabinoids 98

Cannabinoids Pharmaceutical Treatment Patients 98

Canna Care Docs

SEPTEMBER 18, 2020

Patients under the age of 18 must also have a parent or guardian registered as a caregiver on their behalf. Patients may purchase a 90 day supply of their medication. Patients may purchase medical cannabis in oil-based preparations such as lozenges, capsules, and vape pens. Can a Qualifying Patient Grow Cannabis in Virginia?

Pharmaceutical 98

Pharmaceutical Conditions Patients Oil 98

Cannabis Law Report

JULY 7, 2021

Part of larger supply agreement with BOL Pharma to serve rapidly growing number of medical cannabis patients in Israel. We look forward to strengthening our relationship with BOL as we continue to service the growing patient demand for high quality medical cannabis in Israel.”. – Ends – About Curaleaf International.

Research and Development 98

Research and Development Cultivation Extraction Patients 98

Cannabis Law Report

JUNE 28, 2021

He has previously been involved in advocating medical cannabis for the benefit of patients through his work on a number of medical and policy bodies. ABOUT KANABO GROUP PLC: Kanabo is an industry leader in product development and commercialisation of both cannabis-derived products for medical patients and THC-free products for CBD consumers.

Research and Development 105

Research and Development Chronic Pain Medicine Policy 105

Cannabis Law Report

JANUARY 16, 2022

Malaysia’s National Pharmaceutical Regulatory Agency (NPRA) previously approved a prescription medicine derived from cannabis in 2014 to treat muscle spasms and spasticity from multiple sclerosis. Sativex was developed by GW Pharmaceuticals, a maker of cannabinoid therapeutics based in Ireland.

Pharmaceutical 98

Pharmaceutical Research and Development Epilepsy Medicine 98

Cannabis Law Report

JANUARY 19, 2022

(ASX: LGP) (“LGP”), a vertically integrated cannabis manufacturer, that AMP has been appointed as marketer and distributor of LGP medical cannabis extracts to pharmacies and clinics in Germany , including exclusive distributor of LGP’s 20:5 LGP Classic and 10:10 LGP Classic extract oils. ” Ms.

Extraction 52

Extraction Oil Research and Development Medicine 52

United Patients Group

FEBRUARY 7, 2023

Cannabis is an effective treatment for pain and inflammation Cannabis is a natural alternative to pharmaceutical drugs. The most effective way depends on the patient’s condition and overall health status but generally speaking most people prefer inhalation over other methods because it delivers relief quickly (within minutes).

Cannabinoids 116

Cannabinoids Chronic Pain Terpenes THC 116

Cannabis Law Report

JUNE 1, 2022

Pharmadrug GmbH has been active worldwide for almost 40 years as a manufacturer and wholesaler of medicinal products and active pharmaceutical ingredients. Our team in Europe is excited to join forces with new colleagues from Pharmadrug GmbH, with their valuable expertise in the German pharmaceutical market.”

Pharmaceutical 52

Pharmaceutical Medicine Extraction Cannabinoids 52

Veriheal

JANUARY 25, 2022

Patients have expressed their disappointment with quality and pricing, citing the black market or other legal states as much better alternatives. The statement confirms that the farm bill did not legalize products made with CBD extracted from hemp. A theory towards a solution would be for all hemp extracts to be approved by the FDA.

Hemp 98

Hemp Business CBD Seed-To-Sale 98

Cannabis Law Report

DECEMBER 14, 2019

The uptick has been represented in the patient count, as well. Although we note the early stage of the sector in Australia and the associated volatility of a nascent industry, over the same period patient numbers domestically have continued to soar,” Bell and Smith wrote in their note. Learn to profit from cannabis companies.

Pharmaceutical 98

Pharmaceutical Patients Clinical Trials Hemp 98

Cannabis Law Report

JULY 21, 2019

FWB: 8K51)(OTC: WLDCF) (the “Company” or “ ICC ” or “ International Cannabis”) is pleased to announce that the Company has entered into an exclusive supply and commercial rights agreement (the “Agreement”) with licensed New Zealand medical cannabis company, NUBU Pharmaceuticals (“NUBU”). (CSE: WRLD.U)(FWB:

Pharmaceutical 40

Pharmaceutical THC CBD Supply Chain 40